FDA Adverse Event Malfunction Summary report: N

I-STAT EG7+ CARTRIDGE

MDR report key: 22961897 · Received September 4, 2025

Report

Report Number
2245578-2025-00107
Event Type
Malfunction
Date Received
September 4, 2025
Date of Event
August 26, 2025
Report Date
September 30, 2025
Manufacturer
ABBOTT POINT OF CARE INC.
Product Code
CHL
PMA / PMN Number
K940918
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

APOC INCIDENT # (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

Additional Manufacturer Narrative · 0

APOC INCIDENT: # (B)(4). THE INVESTIGATION WAS COMPLETED ON 22-SEP-2025. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) CONFIRMED THE CARTRIDGE LOT MET FINISHED GOODS (FG) RELEASE CRITERIA. RETAINED CARTRIDGE TESTING MET THE ACCEPTANCE CRITERIA OUTLINED IN APPENDIX 1 OF Q04.01.003 REV. AO, PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE. NO DEFICIENCY HAS BEEN IDENTIFIED FOR EG7+ CARTRIDGE LOT N25039.

Description of Event or Problem · 0

ON (B)(6) 2025, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT EG7+ CARTRIDGES THAT YIELDED A SUSPECTED DESCREPANT PO2 RESULTS ON A PATIENT. THERE WAS NO PATIENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT. RETURN PRODUCT IS NOT AVAILABLE FOR INVESTIGATION. TEST DATE: (B)(6) 2025. METHOD, COLLECTED, TESTED PH, PCO2, PO2, BEECF, HCO3, TCO2, SO2, NA, K, ICA, HCT, HB SAMPLE. I-STAT, 21:00, 21:03, 6.881 >130.0, 243, 130, 5.5, 1.11, 34, 11.6, 1. I-STAT, 22:32, 22:32, 6.985 >130.0, 240, 137, 4.7 1.05, 32, 10.9, 2. TEST DATE: (B)(6) 2025. METHOD, COLLECTED, TESTED, PH, PCO2, PO2, BEECF, HCO3, TCO2, SO2, NA, K, ICA, HCT, HB CL, SBC SAMPLE. I-STAT, 09:15, 09:18, 7.134 >130, 12, 149, 4.0, 0.93, 31, 10.5, 3. HDC-LYT, 12:15, 12:25, 7.109, 123, 65.47, 12.55, 42.26, 46.22, 90.80, 168, 5.42, 3.65, 37.3, 12.43, 96.4, 32.42, 4. AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON INFORMATION AVAILABLE THAT SUGGESTS THE PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY OF THE ASSAY. THE INVESTIGATION IS UNDERWAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1292634 I-STAT EG7+ CARTRIDGE EG7+ CARTRIDGE CHL ABBOTT POINT OF CARE INC. NA N25039

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown